ELV earnings: next report 2026-10-20, real EPS beat/miss history, analyst consensus Buy, P/E 17.29. Updated 2026-07-23.
Elevance Health (ELV) Research Hub
Elevance Health (ELV) trades on NYSE, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-09-11, shares last closed at 418.72 USD (+5.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 17.29, market cap 84.11B. This hub links to the full technical, earnings and options research available for ELV.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NYSE, US |
| Last close | 418.72 USD (+5.50%) |
| 52-week range | 362.98 USD – 427.64 USD |
| Trend regime | Range |
| 14-day RSI | 61.8 (Bullish) |
| Trailing P/E | 17.29 |
| Market cap | 84.11B |
| Dividend yield | 1.76% |
| Next earnings | 2026-10-20 |
Available research for ELV
Covered Call on ELV: how it works, illustrative setup around the real 418.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELV: how it works, illustrative setup around the real 418.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELV: how it works, illustrative setup around the real 418.72 USD price, max profit/loss, breakeven and when to use it. Educational.
ELV technical analysis: range, last 418.72 USD, RSI 61.8, 52w range 362.98 USD–427.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ELV in?
Elevance Health (ELV) is classified under Healthcare (Medical - Healthcare Plans), listed on NYSE, US.
Is ELV in an uptrend or downtrend?
As of 2026-09-11, ELV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELV's trailing P/E ratio?
ELV's trailing P/E is 17.29, with a market cap of 84.11B. See the earnings research page for full valuation detail.
When does ELV next report earnings?
ELV is next scheduled to report earnings on 2026-10-20, with a consensus EPS estimate of 4.79 USD.